VCNX Vaccinex Inc
5,512
$5.54
$0.0034
(0.06%)
| Watchers | 5,512 |
| 52-Wk Low | $4.43 |
| 52-Wk High | $100.80 |
| Market Cap | $7.89M |
| Volume | 3,418.00 |
| 52-Wk High | $100.80 |
| 52-Wk Low | $4.43 |
Vaccinex Reports 2023 Financial Results and Provides Corporate UpdateGlobe Newswire • about 2 months ago
Expect Topline Data for Phase 1/2a Randomized SIGNAL-AD Study of Pepinemab for Alzheimer's Disease in Q3 2024 Company raised $17.9 million of new financing during Q4 2023 and Q1 2024 ROCHESTER...
Share to Feed
Vaccinex, Inc. (NASDAQ:VCNX - Get Free Report) saw a significant decline in short interest in March. As of March 15th, there was short interest totalling 8,800 shares, a decline of 40.5% from the...
Vaccinex to raise $1.5M through in a direct offering...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
ROCHESTER, N.Y., March 27, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) ( Vaccinex or the Company ), a clinical-stage biotechnology company pioneering a differentiated approach to...
Acciones al alza
ZyVersa Therapeutics (NASDAQ:ZVSA) avanzaron un 47,31% para establecerse en los 1,18 d lares durante la sesi n del pre-market del lunes.
Vaccinex (NASDAQ:VCNX) crecieron un 43,64...
Eight new antibody discovery agreements incorporate Vaccinex's powerful ActivMAb Drug Discovery Platform ActivMab platform enables the discovery and development of high value antibodies against...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
ROCHESTER, N.Y., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc., (NASDAQ: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease...
Gagnants
L'action Vaccinex (NASDAQ:VCNX) a grimp vendredi de 12,48% 0,78 dollars lors de la session after-market.
Le titre Celularity (NASDAQ:CELU) a augment de 7,52% 0,46 dollars.
L'action...